
|Articles|April 15, 2006
AGS collects ideas for helping glaucoma patients with compliance
Ophthalmologists have long been frustrated by their inability to stop or reverse glaucoma. Once the diagnosis has been made, they try valiantly to preserve what vision remains.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


